PMA P010029S043
- Device
- EUFLEXXA® (1% sodium hyaluronate)
- Applicant
- Ferring Pharmaceuticals, Inc.
- PMA number
- P010029
- Supplement
- S043
- Product code
- MOZ
- Decision date
- 2026-09-02
- Classification
- Orthopedic
- Generic name
- Acid, hyaluronic, intraarticular
- Approval order statement
- introduction of a new Working Cell Bank (WCB) "WC18-16072025"
Current openFDA PMA Record#
- Device
- EUFLEXXA® (1% sodium hyaluronate)
- Applicant
- Ferring Pharmaceuticals, Inc.
- PMA number
- P010029
- Supplement
- S043
- Product code
- MOZ
- Generic name
- Acid, hyaluronic, intraarticular
- Decision date
- 2026-09-02
- Decision code
- OK30
- Date received
- 2026-08-04
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Approval order statement
- introduction of a new Working Cell Bank (WCB) "WC18-16072025"